Prinston Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for PRINSTON INC
PRINSTON INC has ninety-three approved drugs.
There are three tentative approvals on PRINSTON INC drugs.
Summary for Prinston Inc
| US Patents: | 0 |
| Tradenames: | 82 |
| Ingredients: | 81 |
| NDAs: | 93 |
Drugs and US Patents for Prinston Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prinston Inc | CYCLOBENZAPRINE HYDROCHLORIDE | cyclobenzaprine hydrochloride | TABLET;ORAL | 077797-002 | Feb 28, 2007 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Prinston Inc | BUPROPION HYDROCHLORIDE | bupropion hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 202304-003 | May 26, 2015 | AB1 | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Prinston Inc | QUETIAPINE FUMARATE | quetiapine fumarate | TABLET, EXTENDED RELEASE;ORAL | 208781-001 | Apr 26, 2022 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| Prinston Inc | LOSARTAN POTASSIUM | losartan potassium | TABLET;ORAL | 091497-003 | Jun 6, 2011 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
